Long Read Sequencing Market By Techniques (Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Others), By Product (Instruments, Consumables, Services), By Application (Research Applications, Clinical Applications), By End User (Academic and Govern
Description
Long Read Sequencing Market By Techniques (Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Others), By Product (Instruments, Consumables, Services), By Application (Research Applications, Clinical Applications), By End User (Academic and Government Research Institutes, Pharmaceutical and Biotech Companies, Hospitals and Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Long-read sequencing is a class of DNA sequencing technique and is also known the third-generation sequencing. It aids in overcoming and coping with throughput, scope, and accuracy application limits in genomics. In comparison to short-read sequencing, it has a variety of benefits such as short-read sequencing can only create up to 600 bases of DNA, while as long read sequencing technology may produce reads of more than 10,000 bases. Extensive application of this technological environment is expected to result in an improvement in comprehension of evolution of pathogens, cancer, genetic variety, and drug resistance in intricate sections of genome that are crucial for clinical care.
Major factors that drive growth of the global long read sequencing market include rise in utilization of sequence analysis methodologies and surge in demand for genome mapping program. In addition, increase in investments by key players toward R&D related to long-read sequencing technologies and rise in prevalence of genetic disorders and chronic diseases such as cancer further propel the market growth. However, lack of skilled professionals, and ethical and legal limitations are expected to restrain growth of the long-read sequencing market during the forecast period. In addition, nanopore sequencer has a lower read accuracy when compared to short read sequencers, which further hampers growth of the market. Conversely, use of cloud computing as a potential data management service and high growth potential in untapped emerging countries are anticipated to provide lucrative opportunities among the market players.
The long-read sequencing market is segmented on the basis of technology, product, application, end user, and region. By technique, the market is categorized into single-molecule real-time sequencing (SMRT), nanopore sequencing, and others. On the basis of product, it is segmented into instruments, consumables, and services. By application, it is bifurcated into clinical application and research application. By end user, it is segregated into academic & government research institutes, pharmaceutical & biotechnological companies, hospitals & clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Major companies profiled in the report include Agilent Technologies, Inc. BaseClear BV, Cantata Bio, F. Hoffmann-La Roche Ltd., Future Genomics Technologies, The Genome Transcription Facility of Bordeaux, Grandomics, Jiangsu Hengrui Pharmaceutical Co.Ltd., MicrobesNG, Novogene, Oxford Nanopore Technologies, Pacific Biosciences Inc., St Vincent's Hospital Australia, Takara Holdings Inc., Thermo Fisher Scientific, Inc., Element Biosciences, and Illumina, Inc.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the long read sequencing market analysis from 2021 to 2031 to identify the prevailing long read sequencing market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the long read sequencing market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global long read sequencing market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Application
Research Applications
Clinical Applications
By Techniques
Single-Molecule Real-Time Sequencing
Nanopore Sequencing
Others
By Product
Instruments
Type
System
Software
Consumables
Services
By End User
Academic and Government Research Institutes
Pharmaceutical and Biotech Companies
Hospitals and Clinics
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Agilent Technologies
BaseClear B.V
Cantata Bio
Element bioscience
F. Hoffmann-La Roche Ltd
Future Genomics Technologies B.V
Genome Transcriptome Facility of Bordeaux
GrandOmics
JIANGSU HENFRUI PHARMACEUTICALS CO.LTD
llumina, Inc
MicrobesNG
NOVOGENE
Oxford Nanopore Technologies Limited
Pacific Biosciences of California, Inc
Takara Bio, Inc
Thermo Fisher Scientific, Inc.
St Vincents Hospital Austrailia
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Long-read sequencing is a class of DNA sequencing technique and is also known the third-generation sequencing. It aids in overcoming and coping with throughput, scope, and accuracy application limits in genomics. In comparison to short-read sequencing, it has a variety of benefits such as short-read sequencing can only create up to 600 bases of DNA, while as long read sequencing technology may produce reads of more than 10,000 bases. Extensive application of this technological environment is expected to result in an improvement in comprehension of evolution of pathogens, cancer, genetic variety, and drug resistance in intricate sections of genome that are crucial for clinical care.
Major factors that drive growth of the global long read sequencing market include rise in utilization of sequence analysis methodologies and surge in demand for genome mapping program. In addition, increase in investments by key players toward R&D related to long-read sequencing technologies and rise in prevalence of genetic disorders and chronic diseases such as cancer further propel the market growth. However, lack of skilled professionals, and ethical and legal limitations are expected to restrain growth of the long-read sequencing market during the forecast period. In addition, nanopore sequencer has a lower read accuracy when compared to short read sequencers, which further hampers growth of the market. Conversely, use of cloud computing as a potential data management service and high growth potential in untapped emerging countries are anticipated to provide lucrative opportunities among the market players.
The long-read sequencing market is segmented on the basis of technology, product, application, end user, and region. By technique, the market is categorized into single-molecule real-time sequencing (SMRT), nanopore sequencing, and others. On the basis of product, it is segmented into instruments, consumables, and services. By application, it is bifurcated into clinical application and research application. By end user, it is segregated into academic & government research institutes, pharmaceutical & biotechnological companies, hospitals & clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Major companies profiled in the report include Agilent Technologies, Inc. BaseClear BV, Cantata Bio, F. Hoffmann-La Roche Ltd., Future Genomics Technologies, The Genome Transcription Facility of Bordeaux, Grandomics, Jiangsu Hengrui Pharmaceutical Co.Ltd., MicrobesNG, Novogene, Oxford Nanopore Technologies, Pacific Biosciences Inc., St Vincent's Hospital Australia, Takara Holdings Inc., Thermo Fisher Scientific, Inc., Element Biosciences, and Illumina, Inc.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the long read sequencing market analysis from 2021 to 2031 to identify the prevailing long read sequencing market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the long read sequencing market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global long read sequencing market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Application
Research Applications
Clinical Applications
By Techniques
Single-Molecule Real-Time Sequencing
Nanopore Sequencing
Others
By Product
Instruments
Type
System
Software
Consumables
Services
By End User
Academic and Government Research Institutes
Pharmaceutical and Biotech Companies
Hospitals and Clinics
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Agilent Technologies
BaseClear B.V
Cantata Bio
Element bioscience
F. Hoffmann-La Roche Ltd
Future Genomics Technologies B.V
Genome Transcriptome Facility of Bordeaux
GrandOmics
JIANGSU HENFRUI PHARMACEUTICALS CO.LTD
llumina, Inc
MicrobesNG
NOVOGENE
Oxford Nanopore Technologies Limited
Pacific Biosciences of California, Inc
Takara Bio, Inc
Thermo Fisher Scientific, Inc.
St Vincents Hospital Austrailia
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Table of Contents
322 Pages
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: LONG READ SEQUENCING MARKET, BY TECHNIQUES
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Single-Molecule Real-Time Sequencing
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Nanopore Sequencing
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Others
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- CHAPTER 5: LONG READ SEQUENCING MARKET, BY PRODUCT
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Instruments
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.2.4 Instruments Long Read Sequencing Market by Type
- 5.2.4.1 System Market size and forecast, by region
- 5.2.4.2 Software Market size and forecast, by region
- 5.3 Consumables
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Services
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: LONG READ SEQUENCING MARKET, BY APPLICATION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Research Applications
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Clinical Applications
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- CHAPTER 7: LONG READ SEQUENCING MARKET, BY END USER
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Academic and Government Research Institutes
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
- 7.3 Pharmaceutical and Biotech Companies
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
- 7.4 Hospitals and Clinics
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
- 7.5 Others
- 7.5.1 Key market trends, growth factors and opportunities
- 7.5.2 Market size and forecast, by region
- 7.5.3 Market analysis by country
- CHAPTER 8: LONG READ SEQUENCING MARKET, BY REGION
- 8.1 Overview
- 8.1.1 Market size and forecast
- 8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Techniques
- 8.2.3 North America Market size and forecast, by Product
- 8.2.3.1 North America Instruments Long Read Sequencing Market by Type
- 8.2.4 North America Market size and forecast, by Application
- 8.2.5 North America Market size and forecast, by End User
- 8.2.6 North America Market size and forecast, by country
- 8.2.6.1 U.S.
- 8.2.6.1.1 Market size and forecast, by Techniques
- 8.2.6.1.2 Market size and forecast, by Product
- 8.2.6.1.3 Market size and forecast, by Application
- 8.2.6.1.4 Market size and forecast, by End User
- 8.2.6.2 Canada
- 8.2.6.2.1 Market size and forecast, by Techniques
- 8.2.6.2.2 Market size and forecast, by Product
- 8.2.6.2.3 Market size and forecast, by Application
- 8.2.6.2.4 Market size and forecast, by End User
- 8.2.6.3 Mexico
- 8.2.6.3.1 Market size and forecast, by Techniques
- 8.2.6.3.2 Market size and forecast, by Product
- 8.2.6.3.3 Market size and forecast, by Application
- 8.2.6.3.4 Market size and forecast, by End User
- 8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Techniques
- 8.3.3 Europe Market size and forecast, by Product
- 8.3.3.1 Europe Instruments Long Read Sequencing Market by Type
- 8.3.4 Europe Market size and forecast, by Application
- 8.3.5 Europe Market size and forecast, by End User
- 8.3.6 Europe Market size and forecast, by country
- 8.3.6.1 Germany
- 8.3.6.1.1 Market size and forecast, by Techniques
- 8.3.6.1.2 Market size and forecast, by Product
- 8.3.6.1.3 Market size and forecast, by Application
- 8.3.6.1.4 Market size and forecast, by End User
- 8.3.6.2 France
- 8.3.6.2.1 Market size and forecast, by Techniques
- 8.3.6.2.2 Market size and forecast, by Product
- 8.3.6.2.3 Market size and forecast, by Application
- 8.3.6.2.4 Market size and forecast, by End User
- 8.3.6.3 UK
- 8.3.6.3.1 Market size and forecast, by Techniques
- 8.3.6.3.2 Market size and forecast, by Product
- 8.3.6.3.3 Market size and forecast, by Application
- 8.3.6.3.4 Market size and forecast, by End User
- 8.3.6.4 Italy
- 8.3.6.4.1 Market size and forecast, by Techniques
- 8.3.6.4.2 Market size and forecast, by Product
- 8.3.6.4.3 Market size and forecast, by Application
- 8.3.6.4.4 Market size and forecast, by End User
- 8.3.6.5 Spain
- 8.3.6.5.1 Market size and forecast, by Techniques
- 8.3.6.5.2 Market size and forecast, by Product
- 8.3.6.5.3 Market size and forecast, by Application
- 8.3.6.5.4 Market size and forecast, by End User
- 8.3.6.6 Rest of Europe
- 8.3.6.6.1 Market size and forecast, by Techniques
- 8.3.6.6.2 Market size and forecast, by Product
- 8.3.6.6.3 Market size and forecast, by Application
- 8.3.6.6.4 Market size and forecast, by End User
- 8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Techniques
- 8.4.3 Asia-Pacific Market size and forecast, by Product
- 8.4.3.1 Asia-Pacific Instruments Long Read Sequencing Market by Type
- 8.4.4 Asia-Pacific Market size and forecast, by Application
- 8.4.5 Asia-Pacific Market size and forecast, by End User
- 8.4.6 Asia-Pacific Market size and forecast, by country
- 8.4.6.1 Japan
- 8.4.6.1.1 Market size and forecast, by Techniques
- 8.4.6.1.2 Market size and forecast, by Product
- 8.4.6.1.3 Market size and forecast, by Application
- 8.4.6.1.4 Market size and forecast, by End User
- 8.4.6.2 China
- 8.4.6.2.1 Market size and forecast, by Techniques
- 8.4.6.2.2 Market size and forecast, by Product
- 8.4.6.2.3 Market size and forecast, by Application
- 8.4.6.2.4 Market size and forecast, by End User
- 8.4.6.3 India
- 8.4.6.3.1 Market size and forecast, by Techniques
- 8.4.6.3.2 Market size and forecast, by Product
- 8.4.6.3.3 Market size and forecast, by Application
- 8.4.6.3.4 Market size and forecast, by End User
- 8.4.6.4 Australia
- 8.4.6.4.1 Market size and forecast, by Techniques
- 8.4.6.4.2 Market size and forecast, by Product
- 8.4.6.4.3 Market size and forecast, by Application
- 8.4.6.4.4 Market size and forecast, by End User
- 8.4.6.5 South Korea
- 8.4.6.5.1 Market size and forecast, by Techniques
- 8.4.6.5.2 Market size and forecast, by Product
- 8.4.6.5.3 Market size and forecast, by Application
- 8.4.6.5.4 Market size and forecast, by End User
- 8.4.6.6 Rest of Asia-Pacific
- 8.4.6.6.1 Market size and forecast, by Techniques
- 8.4.6.6.2 Market size and forecast, by Product
- 8.4.6.6.3 Market size and forecast, by Application
- 8.4.6.6.4 Market size and forecast, by End User
- 8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Techniques
- 8.5.3 LAMEA Market size and forecast, by Product
- 8.5.3.1 LAMEA Instruments Long Read Sequencing Market by Type
- 8.5.4 LAMEA Market size and forecast, by Application
- 8.5.5 LAMEA Market size and forecast, by End User
- 8.5.6 LAMEA Market size and forecast, by country
- 8.5.6.1 Brazil
- 8.5.6.1.1 Market size and forecast, by Techniques
- 8.5.6.1.2 Market size and forecast, by Product
- 8.5.6.1.3 Market size and forecast, by Application
- 8.5.6.1.4 Market size and forecast, by End User
- 8.5.6.2 Saudi Arabia
- 8.5.6.2.1 Market size and forecast, by Techniques
- 8.5.6.2.2 Market size and forecast, by Product
- 8.5.6.2.3 Market size and forecast, by Application
- 8.5.6.2.4 Market size and forecast, by End User
- 8.5.6.3 South Africa
- 8.5.6.3.1 Market size and forecast, by Techniques
- 8.5.6.3.2 Market size and forecast, by Product
- 8.5.6.3.3 Market size and forecast, by Application
- 8.5.6.3.4 Market size and forecast, by End User
- 8.5.6.4 Rest of LAMEA
- 8.5.6.4.1 Market size and forecast, by Techniques
- 8.5.6.4.2 Market size and forecast, by Product
- 8.5.6.4.3 Market size and forecast, by Application
- 8.5.6.4.4 Market size and forecast, by End User
- CHAPTER 9: COMPANY LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Key developments
- CHAPTER 10: COMPANY PROFILES
- 10.1 Agilent Technologies
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
- 10.2 BaseClear B.V
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
- 10.3 Cantata Bio
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
- 10.4 Element bioscience
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
- 10.5 F. Hoffmann-La Roche Ltd
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
- 10.6 Future Genomics Technologies B.V
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
- 10.7 Genome Transcriptome Facility of Bordeaux
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
- 10.8 GrandOmics
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
- 10.9 JIANGSU HENFRUI PHARMACEUTICALS CO.LTD
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
- 10.10 llumina, Inc
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments
- 10.11 MicrobesNG
- 10.11.1 Company overview
- 10.11.2 Company snapshot
- 10.11.3 Operating business segments
- 10.11.4 Product portfolio
- 10.11.5 Business performance
- 10.11.6 Key strategic moves and developments
- 10.12 NOVOGENE
- 10.12.1 Company overview
- 10.12.2 Company snapshot
- 10.12.3 Operating business segments
- 10.12.4 Product portfolio
- 10.12.5 Business performance
- 10.12.6 Key strategic moves and developments
- 10.13 Oxford Nanopore Technologies Limited
- 10.13.1 Company overview
- 10.13.2 Company snapshot
- 10.13.3 Operating business segments
- 10.13.4 Product portfolio
- 10.13.5 Business performance
- 10.13.6 Key strategic moves and developments
- 10.14 Pacific Biosciences of California, Inc
- 10.14.1 Company overview
- 10.14.2 Company snapshot
- 10.14.3 Operating business segments
- 10.14.4 Product portfolio
- 10.14.5 Business performance
- 10.14.6 Key strategic moves and developments
- 10.15 Takara Bio, Inc
- 10.15.1 Company overview
- 10.15.2 Company snapshot
- 10.15.3 Operating business segments
- 10.15.4 Product portfolio
- 10.15.5 Business performance
- 10.15.6 Key strategic moves and developments
- 10.16 Thermo Fisher Scientific, Inc.
- 10.16.1 Company overview
- 10.16.2 Company snapshot
- 10.16.3 Operating business segments
- 10.16.4 Product portfolio
- 10.16.5 Business performance
- 10.16.6 Key strategic moves and developments
- 10.17 St Vincents Hospital Austrailia
- 10.17.1 Company overview
- 10.17.2 Company snapshot
- 10.17.3 Operating business segments
- 10.17.4 Product portfolio
- 10.17.5 Business performance
- 10.17.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 2. LONG READ SEQUENCING MARKET SIZE, FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. LONG READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. LONG READ SEQUENCING MARKET SIZE, FOR NANOPORE SEQUENCING, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. LONG READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. LONG READ SEQUENCING MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 7. LONG READ SEQUENCING MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 8. GLOBAL LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 9. LONG READ SEQUENCING MARKET SIZE, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. LONG READ SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. GLOBAL INSTRUMENTS LONG READ SEQUENCING MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 12. LONG READ SEQUENCING MARKET, FOR SYSTEM, BY REGION, 2021-2031 ($MILLION)
- TABLE 13. LONG READ SEQUENCING MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. LONG READ SEQUENCING MARKET SIZE, FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. LONG READ SEQUENCING MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 16. LONG READ SEQUENCING MARKET SIZE, FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. LONG READ SEQUENCING MARKET FOR SERVICES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 18. GLOBAL LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 19. LONG READ SEQUENCING MARKET SIZE, FOR RESEARCH APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
- TABLE 20. LONG READ SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 21. LONG READ SEQUENCING MARKET SIZE, FOR CLINICAL APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
- TABLE 22. LONG READ SEQUENCING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 23. GLOBAL LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 24. LONG READ SEQUENCING MARKET SIZE, FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2021-2031 ($MILLION)
- TABLE 25. LONG READ SEQUENCING MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 26. LONG READ SEQUENCING MARKET SIZE, FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 27. LONG READ SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 28. LONG READ SEQUENCING MARKET SIZE, FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 29. LONG READ SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 30. LONG READ SEQUENCING MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 31. LONG READ SEQUENCING MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 32. LONG READ SEQUENCING MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 33. NORTH AMERICA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 34. NORTH AMERICA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 35. NORTH AMERICA INSTRUMENTS LONG READ SEQUENCING MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 36. NORTH AMERICA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 37. NORTH AMERICA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 38. NORTH AMERICA LONG READ SEQUENCING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 39. U.S. LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 40. U.S. LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 41. U.S. LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 42. U.S. LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 43. CANADA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 44. CANADA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 45. CANADA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 46. CANADA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 47. MEXICO LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 48. MEXICO LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 49. MEXICO LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 50. MEXICO LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 51. EUROPE LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 52. EUROPE LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 53. EUROPE INSTRUMENTS LONG READ SEQUENCING MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 54. EUROPE LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 55. EUROPE LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 56. EUROPE LONG READ SEQUENCING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 57. GERMANY LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 58. GERMANY LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 59. GERMANY LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 60. GERMANY LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 61. FRANCE LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 62. FRANCE LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 63. FRANCE LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 64. FRANCE LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 65. UK LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 66. UK LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 67. UK LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 68. UK LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 69. ITALY LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 70. ITALY LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 71. ITALY LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 72. ITALY LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 73. SPAIN LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 74. SPAIN LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 75. SPAIN LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 76. SPAIN LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 77. REST OF EUROPE LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 78. REST OF EUROPE LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 79. REST OF EUROPE LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 80. REST OF EUROPE LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 81. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 82. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 83. ASIA-PACIFIC INSTRUMENTS LONG READ SEQUENCING MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 84. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 85. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 86. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 87. JAPAN LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 88. JAPAN LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 89. JAPAN LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 90. JAPAN LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 91. CHINA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 92. CHINA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 93. CHINA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 94. CHINA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 95. INDIA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 96. INDIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 97. INDIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 98. INDIA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 99. AUSTRALIA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 100. AUSTRALIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 101. AUSTRALIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 102. AUSTRALIA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 103. SOUTH KOREA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 104. SOUTH KOREA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 105. SOUTH KOREA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 106. SOUTH KOREA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 107. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 108. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 109. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 110. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 111. LAMEA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 112. LAMEA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 113. LAMEA INSTRUMENTS LONG READ SEQUENCING MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 114. LAMEA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 115. LAMEA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 116. LAMEA LONG READ SEQUENCING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 117. BRAZIL LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 118. BRAZIL LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 119. BRAZIL LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 120. BRAZIL LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 121. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 122. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 123. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 124. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 125. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 126. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 127. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 128. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 129. REST OF LAMEA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 130. REST OF LAMEA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 131. REST OF LAMEA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 132. REST OF LAMEA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 133.AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
- TABLE 134.AGILENT TECHNOLOGIES: OPERATING SEGMENTS
- TABLE 135.AGILENT TECHNOLOGIES: PRODUCT PORTFOLIO
- TABLE 136.AGILENT TECHNOLOGIES: NET SALES,
- TABLE 137.AGILENT TECHNOLOGIES: KEY STRATERGIES
- TABLE 138.BASECLEAR B.V: COMPANY SNAPSHOT
- TABLE 139.BASECLEAR B.V: OPERATING SEGMENTS
- TABLE 140.BASECLEAR B.V: PRODUCT PORTFOLIO
- TABLE 141.BASECLEAR B.V: NET SALES,
- TABLE 142.BASECLEAR B.V: KEY STRATERGIES
- TABLE 143.CANTATA BIO: COMPANY SNAPSHOT
- TABLE 144.CANTATA BIO: OPERATING SEGMENTS
- TABLE 145.CANTATA BIO: PRODUCT PORTFOLIO
- TABLE 146.CANTATA BIO: NET SALES,
- TABLE 147.CANTATA BIO: KEY STRATERGIES
- TABLE 148.ELEMENT BIOSCIENCE: COMPANY SNAPSHOT
- TABLE 149.ELEMENT BIOSCIENCE: OPERATING SEGMENTS
- TABLE 150.ELEMENT BIOSCIENCE: PRODUCT PORTFOLIO
- TABLE 151.ELEMENT BIOSCIENCE: NET SALES,
- TABLE 152.ELEMENT BIOSCIENCE: KEY STRATERGIES
- TABLE 153.F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
- TABLE 154.F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
- TABLE 155.F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
- TABLE 156.F. HOFFMANN-LA ROCHE LTD: NET SALES,
- TABLE 157.F. HOFFMANN-LA ROCHE LTD: KEY STRATERGIES
- TABLE 158.FUTURE GENOMICS TECHNOLOGIES B.V: COMPANY SNAPSHOT
- TABLE 159.FUTURE GENOMICS TECHNOLOGIES B.V: OPERATING SEGMENTS
- TABLE 160.FUTURE GENOMICS TECHNOLOGIES B.V: PRODUCT PORTFOLIO
- TABLE 161.FUTURE GENOMICS TECHNOLOGIES B.V: NET SALES,
- TABLE 162.FUTURE GENOMICS TECHNOLOGIES B.V: KEY STRATERGIES
- TABLE 163.GENOME TRANSCRIPTOME FACILITY OF BORDEAUX: COMPANY SNAPSHOT
- TABLE 164.GENOME TRANSCRIPTOME FACILITY OF BORDEAUX: OPERATING SEGMENTS
- TABLE 165.GENOME TRANSCRIPTOME FACILITY OF BORDEAUX: PRODUCT PORTFOLIO
- TABLE 166.GENOME TRANSCRIPTOME FACILITY OF BORDEAUX: NET SALES,
- TABLE 167.GENOME TRANSCRIPTOME FACILITY OF BORDEAUX: KEY STRATERGIES
- TABLE 168.GRANDOMICS: COMPANY SNAPSHOT
- TABLE 169.GRANDOMICS: OPERATING SEGMENTS
- TABLE 170.GRANDOMICS: PRODUCT PORTFOLIO
- TABLE 171.GRANDOMICS: NET SALES,
- TABLE 172.GRANDOMICS: KEY STRATERGIES
- TABLE 173.JIANGSU HENFRUI PHARMACEUTICALS CO.LTD: COMPANY SNAPSHOT
- TABLE 174.JIANGSU HENFRUI PHARMACEUTICALS CO.LTD: OPERATING SEGMENTS
- TABLE 175.JIANGSU HENFRUI PHARMACEUTICALS CO.LTD: PRODUCT PORTFOLIO
- TABLE 176.JIANGSU HENFRUI PHARMACEUTICALS CO.LTD: NET SALES,
- TABLE 177.JIANGSU HENFRUI PHARMACEUTICALS CO.LTD: KEY STRATERGIES
- TABLE 178.LLUMINA, INC: COMPANY SNAPSHOT
- TABLE 179.LLUMINA, INC: OPERATING SEGMENTS
- TABLE 180.LLUMINA, INC: PRODUCT PORTFOLIO
- TABLE 181.LLUMINA, INC: NET SALES,
- TABLE 182.LLUMINA, INC: KEY STRATERGIES
- TABLE 183.MICROBESNG: COMPANY SNAPSHOT
- TABLE 184.MICROBESNG: OPERATING SEGMENTS
- TABLE 185.MICROBESNG: PRODUCT PORTFOLIO
- TABLE 186.MICROBESNG: NET SALES,
- TABLE 187.MICROBESNG: KEY STRATERGIES
- TABLE 188.NOVOGENE: COMPANY SNAPSHOT
- TABLE 189.NOVOGENE: OPERATING SEGMENTS
- TABLE 190.NOVOGENE: PRODUCT PORTFOLIO
- TABLE 191.NOVOGENE: NET SALES,
- TABLE 192.NOVOGENE: KEY STRATERGIES
- TABLE 193.OXFORD NANOPORE TECHNOLOGIES LIMITED: COMPANY SNAPSHOT
- TABLE 194.OXFORD NANOPORE TECHNOLOGIES LIMITED: OPERATING SEGMENTS
- TABLE 195.OXFORD NANOPORE TECHNOLOGIES LIMITED: PRODUCT PORTFOLIO
- TABLE 196.OXFORD NANOPORE TECHNOLOGIES LIMITED: NET SALES,
- TABLE 197.OXFORD NANOPORE TECHNOLOGIES LIMITED: KEY STRATERGIES
- TABLE 198.PACIFIC BIOSCIENCES OF CALIFORNIA, INC: COMPANY SNAPSHOT
- TABLE 199.PACIFIC BIOSCIENCES OF CALIFORNIA, INC: OPERATING SEGMENTS
- LIST OF FIGURES
- FIGURE 1.LONG READ SEQUENCING MARKET SEGMENTATION
- FIGURE 2.LONG READ SEQUENCING MARKET,2021-2031
- FIGURE 3.LONG READ SEQUENCING MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.LONG READ SEQUENCING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.LONG READ SEQUENCING MARKET,BY TECHNIQUES,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SINGLE-MOLECULE REAL-TIME SEQUENCING LONG READ SEQUENCING MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF NANOPORE SEQUENCING LONG READ SEQUENCING MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF OTHERS LONG READ SEQUENCING MARKET,2021-2031(%)
- FIGURE 16.LONG READ SEQUENCING MARKET,BY PRODUCT,2021(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS LONG READ SEQUENC
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
